Sygnature Discovery is a leading integrated drug discovery Contract Research Organisation (CRO) based in the UK. They provide comprehensive drug discovery resources and expertise across a range of therapeutic and biological target classes, aiming to accelerate clients' research activities in creating better drugs for patients.
Focus Areas
Notable Investments
